EDSA (Edesa Biotech) FCF Margin %: 0.00% (As of Mar. 2026)


EDSA Edesa Biotech Inc EDSA
26 GF Score
Price $7.95
! 2 Warning Signs
View Full Analysis

What is Edesa Biotech FCF Margin %?

Edesa Biotech EDSA +5.58% 26 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates EDSA with a GF Score™ of 26/100. The stock has 2 warning signs investors should review. Among 959 Biotechnology companies, Edesa Biotech ranks worse than 104275.18% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Edesa Biotech's Free Cash Flow for the three months ended in Mar. 2026 was $-2.02 Mil. Edesa Biotech's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Edesa Biotech's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Edesa Biotech's current FCF Yield % is -9.83%.

The historical rank and industry rank for Edesa Biotech's FCF Margin % or its related term are showing as below:


During the past 13 years, the highest FCF Margin % of Edesa Biotech was -385.85%. The lowest was -2358.02%. And the median was -1525.84%.

EDSA's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -84.65
* Ranked among companies with meaningful FCF Margin % only.

Edesa Biotech FCF Margin % Related Terms

Edesa Biotech FCF Margin % Historical Data

* Premium members only.

The historical data trend for Edesa Biotech's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edesa Biotech FCF Margin % Chart

Edesa Biotech Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Edesa Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

EDSA vs PMVP, IMA, ENTX: FCF Margin % Comparison

For the Biotechnology subindustry, Edesa Biotech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Edesa Biotech FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Edesa Biotech's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Edesa Biotech's FCF Margin % falls into.


EDSA
26GF Score
Edesa Biotech Inc EDSA
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Edesa Biotech FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Edesa Biotech's FCF Margin for the fiscal year that ended in Sep. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Sep. 2025 )/Revenue (A: Sep. 2025 )
=-7.322/0
= %

Edesa Biotech's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-2.017/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Edesa Biotech (EDSA) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Edesa Biotech and its competitors. According to the industry distribution chart, Edesa Biotech ranks #999999 out of 959 companies in the Biotechnology industry.
Is Edesa Biotech's FCF Margin % too high?
Edesa Biotech's current FCF Margin % is 0.00%. Based on the distribution chart, Edesa Biotech ranks #999999 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Edesa Biotech has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Edesa Biotech's FCF Margin % compare to PMVP and IMA?
According to the Biotechnology industry distribution chart, Edesa Biotech ranks #999999 out of 959 companies for FCF Margin %. This places Edesa Biotech in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Edesa Biotech and its competitors. Edesa Biotech's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Edesa Biotech stock overvalued right now?
Edesa Biotech (EDSA) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Edesa Biotech's overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Edesa Biotech (EDSA), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Edesa Biotech Business Description

Address 100 Spy Court, Markham, ON, CAN, L3R 5H6
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
26GF Score

Get the complete analysis for EDSA

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.95
Price